BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27830803)

  • 1. Peer review: Revise rules on conflicts of interest.
    Žliobaitė I; Fortelius M
    Nature; 2016 Nov; 539(7628):168. PubMed ID: 27830803
    [No Abstract]   [Full Text] [Related]  

  • 2. Who stands to lose from double-blind review?
    Garvalov BK
    Nature; 2008 Mar; 452(7183):28. PubMed ID: 18322505
    [No Abstract]   [Full Text] [Related]  

  • 3. Who would you share your funding with?
    Bollen J
    Nature; 2018 Aug; 560(7717):143. PubMed ID: 30089925
    [No Abstract]   [Full Text] [Related]  

  • 4. Nature journals tighten rules on non-financial conflicts.
    Nature; 2018 Feb; 554(7690):6. PubMed ID: 29388964
    [No Abstract]   [Full Text] [Related]  

  • 5. On peer review.
    Schuklenk U
    Bioethics; 2015 Feb; 29(2):ii-iii. PubMed ID: 25586285
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of revealing authors' conflicts of interests in peer review: randomized controlled trial.
    John LK; Loewenstein G; Marder A; Callaham ML
    BMJ; 2019 Nov; 367():l5896. PubMed ID: 31694810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical guidelines to publication of chemical research.
    Editors of the Publications Division, Ameican Chemical Society
    Biomacromolecules; 2001; 2(1):19A-21A. PubMed ID: 12442743
    [No Abstract]   [Full Text] [Related]  

  • 8. Peer-review system could gain from author feedback.
    Korngreen A
    Nature; 2005 Nov; 438(7066):282. PubMed ID: 16292281
    [No Abstract]   [Full Text] [Related]  

  • 9. EURYI: present procedure risks conflicts of interest.
    Lente G
    Nature; 2005 Sep; 437(7056):192. PubMed ID: 16148909
    [No Abstract]   [Full Text] [Related]  

  • 10. The politics of publication.
    Lawrence PA
    Nature; 2003 Mar; 422(6929):259-61. PubMed ID: 12646895
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigator-initiated trials are more impartial.
    Johnston BC; Vohra S
    Nature; 2006 Sep; 443(7108):144. PubMed ID: 16971926
    [No Abstract]   [Full Text] [Related]  

  • 12. The system rewards a dishonest approach.
    Brookfield J
    Nature; 2003 May; 423(6939):480; discussion 480. PubMed ID: 12774095
    [No Abstract]   [Full Text] [Related]  

  • 13. A simple system of checks and balances to cut fraud.
    Yang X; Eggan K; Seidel G; Jaenisch R; Melton D
    Nature; 2006 Feb; 439(7078):782. PubMed ID: 16482128
    [No Abstract]   [Full Text] [Related]  

  • 14. Protecting our science.
    Seixas NS
    Ann Occup Hyg; 2013 Oct; 57(8):963-5. PubMed ID: 24130260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific research and the human condition.
    Perez Velazquez JL
    Nature; 2003 Jan; 421(6918):13. PubMed ID: 12511929
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind review: the paw print is a giveaway.
    Naqvi KR
    Nature; 2008 Mar; 452(7183):28. PubMed ID: 18322504
    [No Abstract]   [Full Text] [Related]  

  • 17. China cracks down on fake peer reviews.
    Cyranoski D
    Nature; 2017 Jun; 546(7659):464. PubMed ID: 28640278
    [No Abstract]   [Full Text] [Related]  

  • 18. A rebuttal: secret ties to industry and conflicting interests in cancer research.
    McLaughlin JK; Boice JD; Tarone RE; Blot WJ
    Am J Ind Med; 2007 Mar; 50(3):235-6. PubMed ID: 17187382
    [No Abstract]   [Full Text] [Related]  

  • 19. Ten simple rules for reviewers.
    Bourne PE; Korngreen A
    PLoS Comput Biol; 2006 Sep; 2(9):e110. PubMed ID: 17009861
    [No Abstract]   [Full Text] [Related]  

  • 20. Citation rate unrelated to journals' impact factors.
    Waheed AA
    Nature; 2003 Dec; 426(6966):495. PubMed ID: 14654813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.